136 related articles for article (PubMed ID: 25781635)
1. Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic mice.
Cao D; Jiang J; Tsukamoto T; Liu R; Ma L; Jia Z; Kong F; Oshima M; Cao X
PLoS One; 2015; 10(3):e0120938. PubMed ID: 25781635
[TBL] [Abstract][Full Text] [Related]
2. 4-Vinyl-2,6-dimethoxyphenol (canolol) suppresses oxidative stress and gastric carcinogenesis in Helicobacter pylori-infected carcinogen-treated Mongolian gerbils.
Cao X; Tsukamoto T; Seki T; Tanaka H; Morimura S; Cao L; Mizoshita T; Ban H; Toyoda T; Maeda H; Tatematsu M
Int J Cancer; 2008 Apr; 122(7):1445-54. PubMed ID: 18059022
[TBL] [Abstract][Full Text] [Related]
3. The role of PGE2-associated inflammatory responses in gastric cancer development.
Oshima H; Oshima M
Semin Immunopathol; 2013 Mar; 35(2):139-50. PubMed ID: 23053397
[TBL] [Abstract][Full Text] [Related]
4. Protection from inflammatory bowel disease and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) involves suppression of oxidative stress and inflammatory cytokines.
Fang J; Seki T; Tsukamoto T; Qin H; Yin H; Liao L; Nakamura H; Maeda H
Carcinogenesis; 2013 Dec; 34(12):2833-41. PubMed ID: 24064222
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway.
Oshima H; Matsunaga A; Fujimura T; Tsukamoto T; Taketo MM; Oshima M
Gastroenterology; 2006 Oct; 131(4):1086-95. PubMed ID: 17030179
[TBL] [Abstract][Full Text] [Related]
6. Roles of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression and beta-catenin activation in gastric carcinogenesis in N-methyl-N-nitrosourea-treated K19-C2mE transgenic mice.
Takasu S; Tsukamoto T; Cao XY; Toyoda T; Hirata A; Ban H; Yamamoto M; Sakai H; Yanai T; Masegi T; Oshima M; Tatematsu M
Cancer Sci; 2008 Dec; 99(12):2356-64. PubMed ID: 19018769
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Han TS; Voon DC; Oshima H; Nakayama M; Echizen K; Sakai E; Yong ZWE; Murakami K; Yu L; Minamoto T; Ock CY; Jenkins BJ; Kim SJ; Yang HK; Oshima M
Gastroenterology; 2019 Mar; 156(4):1140-1155.e4. PubMed ID: 30508510
[TBL] [Abstract][Full Text] [Related]
8. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.
Oshima M; Oshima H; Matsunaga A; Taketo MM
Cancer Res; 2005 Oct; 65(20):9147-51. PubMed ID: 16230370
[TBL] [Abstract][Full Text] [Related]
9. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways.
Echizen K; Hirose O; Maeda Y; Oshima M
Cancer Sci; 2016 Apr; 107(4):391-7. PubMed ID: 27079437
[TBL] [Abstract][Full Text] [Related]
10. Dietary canolol induces apoptosis in human cervical carcinoma HeLa cells through ROS-MAPK mediated mitochondrial signaling pathway: In vitro and in vivo.
Xia X; Xiang X; Huang F; Zheng M; Zhang Z; Han L
Chem Biol Interact; 2019 Feb; 300():138-150. PubMed ID: 30653946
[TBL] [Abstract][Full Text] [Related]
11. Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling.
Oshima H; Itadani H; Kotani H; Taketo MM; Oshima M
Cancer Res; 2009 Apr; 69(7):2729-33. PubMed ID: 19318548
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells.
Kong D; Piao YS; Yamashita S; Oshima H; Oguma K; Fushida S; Fujimura T; Minamoto T; Seno H; Yamada Y; Satou K; Ushijima T; Ishikawa TO; Oshima M
Oncogene; 2012 Aug; 31(35):3949-60. PubMed ID: 22139078
[TBL] [Abstract][Full Text] [Related]
13. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer.
Itadani H; Oshima H; Oshima M; Kotani H
BMC Genomics; 2009 Dec; 10():615. PubMed ID: 20015407
[TBL] [Abstract][Full Text] [Related]
14. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y
Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392
[TBL] [Abstract][Full Text] [Related]
15. Myeloid Differentiation Factor 88 Signaling in Bone Marrow-Derived Cells Promotes Gastric Tumorigenesis by Generation of Inflammatory Microenvironment.
Maeda Y; Echizen K; Oshima H; Yu L; Sakulsak N; Hirose O; Yamada Y; Taniguchi T; Jenkins BJ; Saya H; Oshima M
Cancer Prev Res (Phila); 2016 Mar; 9(3):253-63. PubMed ID: 26888865
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes.
Rasheed Z; Rasheed N; Al-Shobaili HA
J Cell Mol Med; 2016 Dec; 20(12):2241-2248. PubMed ID: 27515563
[TBL] [Abstract][Full Text] [Related]
17. Antioxidative and antimutagenic activities of 4-vinyl-2,6-dimethoxyphenol (canolol) isolated from canola oil.
Kuwahara H; Kanazawa A; Wakamatu D; Morimura S; Kida K; Akaike T; Maeda H
J Agric Food Chem; 2004 Jul; 52(14):4380-7. PubMed ID: 15237940
[TBL] [Abstract][Full Text] [Related]
18. Isolation, identification, and structure of a potent alkyl-peroxyl radical scavenger in crude canola oil, canolol.
Wakamatsu D; Morimura S; Sawa T; Kida K; Nakai C; Maeda H
Biosci Biotechnol Biochem; 2005 Aug; 69(8):1568-74. PubMed ID: 16116287
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.
Li P; Shan JX; Chen XH; Zhang D; Su LP; Huang XY; Yu BQ; Zhi QM; Li CL; Wang YQ; Tomei S; Cai Q; Ji J; Li JF; Chouchane L; Yu YY; Sun FZ; Xu ZH; Liu BY; Zhu ZG
Cell Res; 2015 May; 25(5):588-603. PubMed ID: 25916550
[TBL] [Abstract][Full Text] [Related]
20. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
